Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.19.3.a.u2
Commitments and Contingencies (Details)
 1 Months Ended 3 Months Ended 6 Months Ended
Jan. 14, 2014
USD ($)
Apr. 30, 2013
USD ($)
item
Dec. 31, 2015
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total       $ 888,000 $ 1,273,000 $ 1,865,000 $ 2,397,000
Royalty Guarantees, Commitments, Amount       200,000   200,000  
Licensing Fees       150,000 150,000 $ 152,000 152,000
Long Term Purchase Commitment Expire Date           Dec. 31, 2015  
Agreement Term 5 years            
Commitments [Member]              
Commitments and Contingencies [Line Items]              
Long-term Purchase Commitment, Amount     $ 3,000,000        
Royalty Guarantees, Commitments, Amount     $ 3,000,000        
License Cost $ 30,627            
Initial license fee 20,000            
Settlement Agreement [Member]              
Commitments and Contingencies [Line Items]              
Number of Installments | item   3          
Prepaid Expense   $ 1,000,000          
Amended Agreement [Member]              
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total           $ 2,100,000  
Minimum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Cost 25,000            
Maximum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Cost $ 150,000            
Fraunhofer [Member]              
Commitments and Contingencies [Line Items]              
Royalty Guarantees, Commitments, Amount       4,000,000   $ 4,000,000  
Other Commitments, Description           the 2013 Settlement Agreement provided that, for a period of up to 15 years, the Company would pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch(TM) or iBioModulator(TM) technology and ten percent (10%) of all receipts derived by the Company from licensing those technologies to third parties.  
iBio CDMO LLC [Member] | Second Eastern Affiliate [Member]              
Commitments and Contingencies [Line Items]              
Operating Leases, Rent Expense       $ 35,000 $ 54,000 $ 67,000 $ 66,000